T. KUŞ Et Al. , "IS MORE INTENSIVE CHEMOTHERAPYREASONABLE IN GASTRIC CANCER PATIENTSWITH PERITONEAL METASTASIS? AMULTICENTER STUDY," 10.IGICC , 2020
KUŞ, T. Et Al. 2020. IS MORE INTENSIVE CHEMOTHERAPYREASONABLE IN GASTRIC CANCER PATIENTSWITH PERITONEAL METASTASIS? AMULTICENTER STUDY. 10.IGICC .
KUŞ, T., ÖZDEMİR, N., AKTAŞ, G., SÜTCÜOĞLU, O., YALÇINTAŞ ARSLAN, Ü., dirikoc, m., ... KÖSE, F.(2020). IS MORE INTENSIVE CHEMOTHERAPYREASONABLE IN GASTRIC CANCER PATIENTSWITH PERITONEAL METASTASIS? AMULTICENTER STUDY . 10.IGICC
KUŞ, TÜLAY Et Al. "IS MORE INTENSIVE CHEMOTHERAPYREASONABLE IN GASTRIC CANCER PATIENTSWITH PERITONEAL METASTASIS? AMULTICENTER STUDY," 10.IGICC, 2020
KUŞ, TÜLAY Et Al. "IS MORE INTENSIVE CHEMOTHERAPYREASONABLE IN GASTRIC CANCER PATIENTSWITH PERITONEAL METASTASIS? AMULTICENTER STUDY." 10.IGICC , 2020
KUŞ, T. Et Al. (2020) . "IS MORE INTENSIVE CHEMOTHERAPYREASONABLE IN GASTRIC CANCER PATIENTSWITH PERITONEAL METASTASIS? AMULTICENTER STUDY." 10.IGICC .
@conferencepaper{conferencepaper, author={TÜLAY KUŞ Et Al. }, title={IS MORE INTENSIVE CHEMOTHERAPYREASONABLE IN GASTRIC CANCER PATIENTSWITH PERITONEAL METASTASIS? AMULTICENTER STUDY}, congress name={10.IGICC}, city={}, country={}, year={2020}}